Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH).
Publication
, Journal Article
Assimos, DG
Published in: J Urol
September 2018
Duke Scholars
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
September 2018
Volume
200
Issue
3
Start / End Page
492 / 494
Location
United States
Related Subject Headings
- Vitamin D3 24-Hydroxylase
- Urology & Nephrology
- Mutation
- Hypercalcemia
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2018). Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH). J Urol, 200(3), 492–494. https://doi.org/10.1016/j.juro.2018.05.096
Assimos, Dean G. “Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH).” J Urol 200, no. 3 (September 2018): 492–94. https://doi.org/10.1016/j.juro.2018.05.096.
Assimos DG. Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH). J Urol. 2018 Sep;200(3):492–4.
Assimos, Dean G. “Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH).” J Urol, vol. 200, no. 3, Sept. 2018, pp. 492–94. Pubmed, doi:10.1016/j.juro.2018.05.096.
Assimos DG. Re: A Rapid Screening of a Recurrent CYP24A1 Pathogenic Variant Opens the Way to Molecular Testing for Idiopathic Infantile Hypercalcemia (IIH). J Urol. 2018 Sep;200(3):492–494.
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
September 2018
Volume
200
Issue
3
Start / End Page
492 / 494
Location
United States
Related Subject Headings
- Vitamin D3 24-Hydroxylase
- Urology & Nephrology
- Mutation
- Hypercalcemia
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences